AAAAAA
Results:
1-21
|
Results: 21
Authors:
BONACINI M
GOVINDARAJAN S
LINDSAY KL
Citation: M. Bonacini et al., INTRAHEPATIC EXPRESSION OF VIRAL PROTEIN AND FAS AG IN HCV CIRRHOSIS, Hepatology, 28(4), 1998, pp. 802-802
Authors:
KEEFFE EB
IWARSON S
MCMAHON BJ
LINDSAY KL
KOFF RS
MANNS M
BAUMGARTEN R
WIESE M
FOURNEAU M
SAFARY A
CLEMENS R
KRAUSE DS
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Hepatology, 27(3), 1998, pp. 881-886
Authors:
LINDSAY KL
MOSTELLER M
RIZZETTO M
DAVIS GL
OPOLON P
GOLDIN R
GRAY DF
BOEHME R
BROWN N
Citation: Kl. Lindsay et al., SUSTAINED HISTOLOGIC RESPONSE IS COMMON IN THE ABSENCE OF VIROLOGICALRESPONSE TO INTERFERON (IFN) THERAPY FOR CHRONIC HEPATITIS-C (HCV), Gastroenterology, 114(4), 1998, pp. 382-382
Authors:
ROJTER SE
PARK J
LAVALLIE ML
SHER LS
HOFFMAN AH
LOPEZ RR
MAKOWKA L
CARBERRY JN
LINDSAY KL
Citation: Se. Rojter et al., COMMUNITY-BASED SCREENING FOR HEPATITIS-B (HBV) IN A HIGH-RISK URBAN KOREAN POPULATION, Hepatology, 26(4), 1997, pp. 1336-1336
Authors:
LINDSAY KL
Citation: Kl. Lindsay, THERAPY OF HEPATITIS-C - OVERVIEW, Hepatology, 26(3), 1997, pp. 71-77
Authors:
BODENHEIMER HC
LINDSAY KL
DAVIS GL
LEWIS JH
THUNG SN
SEEFF LB
Citation: Hc. Bodenheimer et al., TOLERANCE AND EFFICACY OF ORAL RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS-C - A MULTICENTER TRIAL, Hepatology, 26(2), 1997, pp. 473-477
Authors:
BONACINI M
HADI G
GOVINDARAJAN S
LINDSAY KL
Citation: M. Bonacini et al., UTILITY OF A DISCRIMINANT SCORE FOR DIAGNOSING ADVANCED FIBROSIS OR CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION, The American journal of gastroenterology, 92(8), 1997, pp. 1302-1304
Authors:
NGUYEN TT
SEDGHIVAZIRI A
WILKES LB
MONDALA T
POCKROS PJ
LINDSAY KL
MCHUTCHISON JG
Citation: Tt. Nguyen et al., FLUCTUATIONS IN VIRAL LOAD (HCV RNA) ARE RELATIVELY INSIGNIFICANT IN UNTREATED PATIENTS WITH CHRONIC HCV INFECTION, Journal of viral hepatitis, 3(2), 1996, pp. 75-78
Authors:
LINDSAY KL
DAVIS GL
SCHIFF ER
BODENHEIMER HC
BALART LA
DIENSTAG JL
PERRILLO RP
TAMBURRO CH
GOFF JS
EVERSON GT
SILVA M
KATKOV WN
GOODMAN Z
LAU JYN
MAERTENS G
GOGATE J
SANGHVI B
ALBRECHT J
MILSTEIN S
KNIFFEN J
ROACH K
BRODEUR C
REGENSTEIN F
TAYLOR B
DEMELIA HC
BODICKY C
MILLER BL
DANHOUR G
BARILETTO S
Citation: Kl. Lindsay et al., RESPONSE TO HIGHER DOSES OF INTERFERON ALFA-2B IN PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED MULTICENTER TRIAL, Hepatology, 24(5), 1996, pp. 1034-1040
Authors:
KEEFFE EB
MCMAHON BJ
KOFF RS
LINDSAY KL
MANNS M
IVARSON S
BAUMGARTEN R
WIESE M
KRAUSE DS
FOURNEAU M
SAFARY A
CLEMENS R
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Gastroenterology, 110(4), 1996, pp. 1231-1231
Authors:
LAU JYN
DAVIS GL
PRESCOTT LE
MAERTENS G
LINDSAY KL
QIAN KP
MIZOKAMI M
SIMMONDS P
PERRILLO RP
SCHIFF ER
BODENHEIMER HC
BALART LA
REGENSTEIN F
DIENSTAG JL
KATKOV WN
TAMBURRO CH
GOFF JS
EVERSON GT
GOODMAN Z
ALBRECHT J
Citation: Jyn. Lau et al., DISTRIBUTION OF HEPATITIS-C VIRUS GENOTYPES DETERMINED BY LINE PROBE ASSAY IN PATIENTS WITH CHRONIC HEPATITIS-C SEEN AT TERTIARY REFERRAL CENTERS IN THE UNITED-STATES, Annals of internal medicine, 124(10), 1996, pp. 868
Authors:
FIEL MI
GUIDO M
THUNG SN
LINDSAY KL
DAVIS GL
LEWIS JH
SEEFF L
BODENHEIMER HC
Citation: Mi. Fiel et al., HEPATIC IRON DEPOSITION DURING RIBAVIRIN THERAPY OF CHRONIC HEPATITIS-C, Hepatology, 22(4), 1995, pp. 736-736
Authors:
DESFORGES JF
ATHARI F
COOPER ES
JOHNSON CS
LEMON SM
LINDSAY KL
MCCULLOUGH J
MCINTOSH K
ROSS RK
WHITSETT CF
WITTES J
WRIGHT TL
Citation: Jf. Desforges et al., INFECTIOUS-DISEASE TESTING FOR BLOOD-TRANSFUSIONS, JAMA, the journal of the American Medical Association, 274(17), 1995, pp. 1374-1379
Authors:
LAU JYN
MIZOKAMI M
KOLBERG JA
DAVIS GL
PRESCOTT LE
OHNO T
PERRILLO RP
LINDSAY KL
GISH RG
QIAN KP
KOHARA M
SIMMONDS P
URDEA MS
Citation: Jyn. Lau et al., APPLICATION OF 6 HEPATITIS-C VIRUS GENOTYPING SYSTEMS TO SERA FROM CHRONIC HEPATITIS-C PATIENTS IN THE UNITED-STATES, The Journal of infectious diseases, 171(2), 1995, pp. 281-289
Authors:
MUTCHNICK MG
LINDSAY KL
SCHIFF ER
CUMMINGS GD
APPELMAN HD
Citation: Mg. Mutchnick et al., THYMOSIN-ALPHA-1 TREATMENT OF CHRONIC HEPATITIS-B - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY, Gastroenterology, 108(4), 1995, pp. 1127-1127
Authors:
LINDSAY KL
SPENCER C
NICOLOFF J
MILSTEIN S
DAVIS GL
SCHIFF E
BODENHEIMER H
BALART L
DIENSTAG J
PERRILLO R
TAMBURRO C
EYERSON G
SANGHVI B
ALBRECHT J
Citation: Kl. Lindsay et al., THYROID PEROXIDASE ANTIBODY - A POTENTIAL PREDICTOR OF IFN-ASSOCIATEDTHYROID-DISEASE, Hepatology, 20(4), 1994, pp. 10000168-10000168
Authors:
BODENHEIMER HC
LINDSAY KL
DAVIS GL
LEWIS IH
THUNG SN
MAHANEY K
SEEFF L
Citation: Hc. Bodenheimer et al., TOLERANCE AND EFFICACY OF ORAL RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS-C - A MULTICENTER TRIAL, Hepatology, 20(4), 1994, pp. 10000207-10000207
Authors:
LINDSAY KL
ELSHAHAWY M
MILSTEIN S
VALINLUCK B
RAJAN S
LAGIER R
SANCHEZPESCADOR R
Citation: Kl. Lindsay et al., HCV RNA LEVELS ARE LOWERED DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 20(4), 1994, pp. 10000239-10000239
Authors:
LINDSAY KL
Citation: Kl. Lindsay, MANAGEMENT OF CHRONIC HEPATITIS IN SPECIAL POPULATIONS, The American journal of medicine, 96, 1994, pp. 57-60
Authors:
LINDSAY KL
DAVIS GL
SCHIFF E
BODENHEIMER H
BALART L
DIENSTAG J
PERRILLO R
TAMBURRO C
SILVA M
GOFF C
EVERSON G
SANGHVI B
ALBRECHT J
Citation: Kl. Lindsay et al., LONG-TERM RESPONSE TO HIGHER DOSES OF INTERFERON (IFN) ALFA-2B TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED MULTICENTER TRIAL, Hepatology, 18(4), 1993, pp. 10000106-10000106
Authors:
VALINLUCK B
LINDSAY KL
MILSTEIN S
GOVINDARAJAN S
Citation: B. Valinluck et al., COMPARISON OF SERUM HBV-DNA MEASUREMENT BY 3 DIFFERENT TECHNIQUES, Hepatology, 18(4), 1993, pp. 10000116-10000116
Risultati:
1-21
|